Table 1 Selected baseline characteristics of study participants

From: The effect of L-Carnitine supplementation on clinical symptoms, C-reactive protein and malondialdehyde in obese women with knee osteoarthritis: a double blind randomized controlled trial

  L-carnitine group (n = 34) Placebo group (n = 36) Pa
Age (y) 55.01 ± 7.12 54.43 ± 7.80 0.737
BMI (kg/m2) 33.03 ± 6.67 32.10 ± 4.29 0.471
Height(m) 1.55 ± 0.10 1.56 ± 0.55 0.481
Weight (Kg) 78.69 ± 10.86 78.90 ± 12.17 0.937
Waist circumference (Cm) 105.13 ± 9.04 105.92 ± 10.57 0.728
Hip circumference (Cm) 115.63 ± 9.37 117.87 ± 10.56 0.332
Physical activity 548.01 ± 1131.4 540.01 ± 620.25 0.432
Energy (kcal) 1426.21 ± 344.91 1377.72 ± 406.44 0.577
Carbohydrate (g) 174.76 ± 37.21 177.38 ± 66.75 0.834
Fat (g) 60.83 ± 24.77 56.19 ± 27.55 0.443
Protein (g) 50.52 ± 19.34b 50.63 ± 22.17b 0.455
Education
 Illiterate 3 (7.9) 1 (2.6) 0.29
 Elementary school graduate 18 (47.4) 20 (52.6)  
 Middle and high school graduate 13 (34.2) 14 (36.8)  
 University graduate 4 (10.5) 3 (7.9)  
Occupational status    0.42
 housewife 30 (78.9) 34 (89.5)  
 employee 3 (13.9) 2 (5.3)  
 Retired 5 (7.2) 2 (5.3)  
  1. Mean ± SD (all such values except protein)
  2. aDetermined with the use of independent samples t tests for differences at baseline between L-carnitine and placebo groups
  3. bMedian and IQR (for no normally distributed variables)